Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes
โ Scribed by C. Kasper; J. Zahner; H. Sayer
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 95 KB
- Volume
- 128
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Recombinant human granulocyte colonyโstimulating factor (rhGโCSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhGโCSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients
## Abstract Twenty children 1โ17 (median, 5.5) years of age received GMโCSF during chemotherapyโinduced neutropenia at the dose of 5 ฮผg/kg/day, continued until the absolute neutrophil count (ANC) exceeded 500 ร 10^6^/liter. Twelve children with solid tumors received GMโCSF after courses of conventi